Literature DB >> 22990354

Treatment and blood pressure control in Spain during 2002-2010.

Jose L Llisterri1, Gustavo C Rodriguez-Roca, Carlos Escobar, F Javier Alonso-Moreno, Miguel A Prieto, Vivencio Barrios, Diego González-Alsina, Juan A Divisón, Vicente Pallarés, Pere Beato.   

Abstract

OBJECTIVES: To examine the evolution of hypertension management and blood pressure (BP) control in Spain in the last decade across PRESCAP 2002, 2006 and 2010.
METHODS: The methodology of the three studies was the same. They were multicenter and cross-sectional surveys aimed to determine BP control rates in hypertensive patients in primary care in Spain during 2002, 2006 and 2010, respectively. In each study, patients at least 18 years, with an established diagnosis of hypertension were included. Adequate BP control was defined as BP less than 140/90 mmHg in the general population (<130/85 mmHg in PRESCAP 2002 and less than 130/80 mmHg in PRESCAP 2006 and PRESCAP 2010 for patients with diabetes, chronic kidney disease and cardiovascular disease).
RESULTS: A total of 12,754 patients (mean age 63.3 ± 10.8 years; 57.2% women), 10,520 patients (64.6 ± 11.3 years; 53.7% women) and 12,961 patients (66.3 ± 11.4; 52.0% women) were included in PRESCAP 2002, PRESCAP 2006 and PRESCAP 2010 studies respectively. With regard to BP control rates, 36.1% [95% confidence interval (CI) 35.2-36.9%], 41.4% (95% CI 40.5-42.4%) and 46.3% of patients (95% CI 45.4-47.1%) achieved BP goals in PRESCAP 2002, PRESCAP 2006 and PRESCAP 2010, respectively (P < 0.0001). In PRESCAP 2002, 56% of patients were on monotherapy, 35.6% were taking two drugs and 8.4% at least three drugs. In PRESCAP 2006 these numbers were 44.4, 41.1 and 14.5%, respectively, and in PRESCAP 2010 they were 36.4, 44.1 and 19.5%, respectively (P < 0.0001).
CONCLUSION: BP control rates have improved in Spain from 2002 to 2010. This may be related, at least in part, with the higher use of antihypertensive treatment, particularly combined therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990354     DOI: 10.1097/HJH.0b013e3283592583

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

1.  Are we living longer but less healthy? Trends in mortality and morbidity in Catalonia (Spain), 1994-2011.

Authors:  Aïda Solé-Auró; Manuela Alcañiz
Journal:  Eur J Ageing       Date:  2014-05-21

2.  Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.

Authors:  Jürgen Rehm; Peter Anderson; Jose Angel Arbesu Prieto; Iain Armstrong; Henri-Jean Aubin; Michael Bachmann; Nuria Bastida Bastus; Carlos Brotons; Robyn Burton; Manuel Cardoso; Joan Colom; Daniel Duprez; Gerrit Gmel; Antoni Gual; Ludwig Kraus; Reinhold Kreutz; Helena Liira; Jakob Manthey; Lars Møller; Ľubomír Okruhlica; Michael Roerecke; Emanuele Scafato; Bernd Schulte; Lidia Segura-Garcia; Kevin David Shield; Cristina Sierra; Konstantin Vyshinskiy; Marcin Wojnar; José Zarco
Journal:  BMC Med       Date:  2017-09-28       Impact factor: 8.775

3.  Hypertension Prevalence, Awareness, Treatment, and Control: Should 24-Hour Ambulatory Blood Pressure Monitoring be the Tool of Choice?

Authors:  Anne Marie O'Flynn; Ronan J Curtin; Ivan J Perry; Patricia M Kearney
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-26       Impact factor: 3.738

Review 4.  The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years.

Authors:  Alberto Martínez-Castelao; Juan F Navarro-González; José Luis Górriz; Fernando de Alvaro
Journal:  J Clin Med       Date:  2015-05-28       Impact factor: 4.241

5.  Protocol for assessing the hypotensive effect of evening administration of acetylsalicylic acid: study protocol for a randomized, cross-over controlled trial.

Authors:  Ma Victoria Ruíz-Arzalluz; Ma Cruz Gómez Fernández; Natalia Burgos-Alonso; Ernest Vinyoles; Ricardo San Vicente Blanco; Gonzalo Grandes
Journal:  Trials       Date:  2013-07-27       Impact factor: 2.279

6.  Symptoms associated with an abnormal echocardiogram in elderly primary care hypertension patients.

Authors:  L Ringoir; J W Widdershoven; S S Pedersen; J M Keyzer; V J Pop
Journal:  Neth Heart J       Date:  2014-05       Impact factor: 2.380

7.  Hypertension and chronic kidney disease in Turkey.

Authors:  Sule Sengul; Yunus Erdem; Vecihi Batuman; Sehsuvar Erturk
Journal:  Kidney Int Suppl (2011)       Date:  2013-12

Review 8.  Which thiazide to choose as add-on therapy for hypertension?

Authors:  Vivencio Barrios; Carlos Escobar
Journal:  Integr Blood Press Control       Date:  2014-07-30

9.  Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012.

Authors:  Sule Sengul; Tekin Akpolat; Yunus Erdem; Ulver Derici; Mustafa Arici; Sukru Sindel; Oktay Karatan; Cetin Turgan; Enver Hasanoglu; Sali Caglar; Sehsuvar Erturk
Journal:  J Hypertens       Date:  2016-06       Impact factor: 4.844

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.